JAMP-RISPERIDONE recall in Canada: may contain foreign matter
In plain language
This recall involves JAMP-RISPERIDONE tablets sold in Canada. It's being recalled because the affected batch may contain foreign matter particles. Consult your healthcare provider before stopping use and follow the instructions in the official notice.
What to do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use.
- Contact JAMP PHARMA CORPORATION with questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
JAMP-RISPERIDONE
Lot: ENN064001
Why this matters
May contain foreign matter particles
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: ENN064001
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
May contain foreign matter particles
What should consumers do?
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact JAMP PHARMA CORPORATION with questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. May contain foreign matter particles
When was this product recalled?
This product was recalled on May 30, 2025.
Is the JAMP brand affected by this recall?
Yes, JAMP products are affected by this recall. This recall involves JAMP-RISPERIDONE tablets sold in Canada. It's being recalled because the affected batch may contain foreign matter particles. Consult your healthcare provider before stopping use and follow the instructions in the official notice.